Related references
Note: Only part of the references are listed.Current and future treatment strategies in chronic lymphocytic leukemia
Krish Patel et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
BCL2 and MCL1 inhibitors for hematologic malignancies
Andrew W. Roberts et al.
BLOOD (2021)
Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
Yuying Liu et al.
SCIENCE IMMUNOLOGY (2020)
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study
Wei Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
Zhiwei Zhou et al.
SCIENCE (2020)
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhibin Zhang et al.
NATURE (2020)
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer
Mingxia Jiang et al.
CELL DEATH DISCOVERY (2020)
Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
Cheng-cheng Zhang et al.
APOPTOSIS (2019)
Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation
Corey Rogers et al.
NATURE COMMUNICATIONS (2019)
Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients
Boyu Hu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
K. Fischer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The role of pyroptosis in cancer: pro-cancer or pro-host?
Xiaojing Xia et al.
CELL DEATH & DISEASE (2019)
Induction of Pyroptosis and Its Implications in Cancer Management
Yan-Yang Wang et al.
FRONTIERS IN ONCOLOGY (2019)
Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro
Pian Yu et al.
ACTA PHARMACOLOGICA SINICA (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma
Katja Ursic et al.
BIOELECTROCHEMISTRY (2018)
Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis
Rui Kang et al.
CELL HOST & MICROBE (2018)
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Jipeng Guo et al.
CANCER RESEARCH AND TREATMENT (2018)
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Yupeng Wang et al.
NATURE (2017)
DFNA5 promoter methylation a marker for breast tumorigenesis
Lieselot Croes et al.
Oncotarget (2017)
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Caspases and their substrates
Olivier Julien et al.
CELL DEATH AND DIFFERENTIATION (2017)
Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis
Sameer A. Parikh et al.
BLOOD (2016)
Kruppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling
Katharina Filarsky et al.
HAEMATOLOGICA (2016)
Kruppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling
Katharina Filarsky et al.
HAEMATOLOGICA (2016)
Prognostication of chronic lymphocytic leukemia in the era of new agents
Barbara Eichhorst et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia
Francesco Maura et al.
LEUKEMIA & LYMPHOMA (2015)
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Nobuhiko Kayagaki et al.
NATURE (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans
Ana-Carolina Martinez-Torres et al.
PLOS MEDICINE (2015)
Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression
Qing Wei et al.
LABORATORY INVESTIGATION (2014)
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia
Sonia Fabris et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression
Han-Yu Chuang et al.
BLOOD (2012)
Caspase Substrates and Cellular Remodeling
Emily D. Crawford et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia
T. Herold et al.
LEUKEMIA (2011)
The BCL-2 Family Reunion
Jerry E. Chipuk et al.
MOLECULAR CELL (2010)
Share Paper
